AI assistant
Sending…
NeuroPace Inc — Director's Dealing 2021
Apr 23, 2021
33194_dirs_2021-04-23_1d77fc96-6e39-4334-867d-a79f671a23a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-21
Reporting Person: Fischer Frank M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-21 | Common Stock | P | 50000 | $17.00 | Acquired | 93291 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-21 | Stock Option (Right to Buy) | $17.00 | A | 21698 | Acquired | 2031-04-20 | Common Stock (21698) | Direct |
Footnotes
F1: Reflects shares purchased from the underwriters in the Companys initial public offering.
F2: 1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021.
More from NeuroPace Inc
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 4
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 23